I have to agree with you somewhat, the webinar was fantasy.
More about having conversations with potential partners , consumers and so on.
The only concrete outcomes we have to look forward to are(hopefully);
1. TGA self use RAT approval
2. Febridx FDA approval,
3. additional corporate clients for Professional RAT ( subject to the product passing the current review process).
If the above are achieved , our share price should edge up.
Media Update, page-1630
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
